NCT00846768View on ClinicalTrials.gov

BI 1744 CL With Respimat Once Daily Versus Twice Daily in COPD

PHASE2CompletedINTERVENTIONAL
Enrollment

47

Participants

Timeline

Start Date

February 28, 2009

Primary Completion Date

July 31, 2009

Conditions
Pulmonary Disease, Chronic Obstructive
Interventions
DRUG

BI 1744 CL

Trial Locations (5)

Unknown

1222.26.32008 Boehringer Ingelheim Investigational Site, Genk

1222.26.32006 Boehringer Ingelheim Investigational Site, Ghent

1222.26.32007 Boehringer Ingelheim Investigational Site, Hasselt

1222.26.31002 Boehringer Ingelheim Investigational Site, Eindhoven

1222.26.31001 Boehringer Ingelheim Investigational Site, Heerlen

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT00846768 - BI 1744 CL With Respimat Once Daily Versus Twice Daily in COPD | Biotech Hunter | Biotech Hunter